Breaking News
April 21, 2018 - Scientists publish comprehensive lineage tree of whole adult animal in Science journal
April 21, 2018 - Innovative method based on FluidFM technology could revolutionize biological research
April 21, 2018 - Americans world’s biggest TV addicts, watching four hours a day
April 21, 2018 - Investigational drug may help increase protein levels in babies with spinal muscular atrophy
April 21, 2018 - Study shows distinctions between age groups in predicting and responding to stress at home
April 21, 2018 - Aziyo Biologics, BIOTRONIK enter into US co-distribution agreement
April 21, 2018 - Opiate Use Linked to Early Mortality in IBD Patients
April 21, 2018 - Online ads help pregnant smokers quit
April 21, 2018 - Opioid pain medications may not be safe for hemodialysis patients
April 21, 2018 - Rare variants in non-coding DNA inherited from parents heighten autism risk
April 21, 2018 - A needleless glucose monitor for diabetes patients
April 21, 2018 - BD introduces new informatics and automation solutions for clinical laboratories
April 21, 2018 - Turn Chores Into a Fitness Routine
April 21, 2018 - DNA methylation plays key role in stem cell differentiation
April 21, 2018 - Scientists find link between soil metals and cancer mortality
April 21, 2018 - Experts discuss implications of low calcium intake in global population
April 21, 2018 - GNA Biosolutions to display Pharos V8 Laser PCR instrument at Analytica trade fair
April 21, 2018 - People with vitamin D deficiency may be at greater risk of diabetes
April 21, 2018 - Study findings could open new possibilities for treating cancer with adenovirus
April 21, 2018 - People who use medical marijuana have higher rates of prescription drug use, study finds
April 21, 2018 - Study debunks ‘myth’ that strenuous exercise dampens immunity
April 21, 2018 - FDA approves marijuana based medication for epilepsy treatment
April 21, 2018 - Researchers find novel genes for longevity in mammals
April 21, 2018 - GNA Biosolutions and project partners launch new research project to develop TB diagnostic platform for POC applications
April 21, 2018 - Scientists identify gene responsible for evolution of recombination rates
April 21, 2018 - UConn researchers develop new composite for healing broken load-bearing bones
April 21, 2018 - Study challenges use of whole-brain radiation for small-cell lung cancer patients with brain metastases
April 21, 2018 - People who become physically active after heart attack more likely to live longer, shows research
April 21, 2018 - CPRIT awards $2 million grant to push forward breast cancer research in West Texas
April 21, 2018 - Unhealthy diet damages the development of immature fat cells, study shows
April 21, 2018 - Consumption of protein supplements with meals may provide better weight control
April 21, 2018 - 4 Types of Foods to Help Boost Your Memory
April 21, 2018 - How did gonorrhea become a drug-resistant superbug?
April 21, 2018 - DePuy Synthes announces clinical results related to use of CORAIL Hip System Femoral Stems
April 21, 2018 - New initiative launched to support goals of Human Cell Atlas
April 20, 2018 - Teen patient gets a new lease on life
April 20, 2018 - Cancer Australia launches new framework to improve outcomes for lung cancer patients
April 20, 2018 - ‘Gut-on-a-chip’ model recreates intestinal matrix critical for nutrient absorption
April 20, 2018 - Researchers develop new drug-testing platform for epilepsy
April 20, 2018 - FDA Alert: NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall
April 20, 2018 - Pelizaeus-Merzbacher-like disease type 1 – Genetics Home Reference
April 20, 2018 - Tick-borne diseases reach epidemic levels, panel says
April 20, 2018 - A potential “male pill” without side effects
April 20, 2018 - Researchers discover new information related to rare form of leukemia
April 20, 2018 - Researchers find crucial links between dopamine and avoidance behavior
April 20, 2018 - UGA scientist creates system for efficient detection of foodborne pathogens
April 20, 2018 - Social Support of Autonomy Tied to Better Glycemic Control in DM
April 20, 2018 - Study reports use of nutritional ketosis with mobile app intervention could reverse Type 2 diabetes
April 20, 2018 - New microscopy techniques allow quasi-biochemical studies on living T cells
April 20, 2018 - Study shows connection between muscular strength and brain health
April 20, 2018 - Ecolab introduces Life Sciences cleanroom program in North America
April 20, 2018 - Normal weight people with fat belly may have more chance of heart problems
April 20, 2018 - Male fruit flies like sex and alcohol
April 20, 2018 - Meditation could help reduce anxiety levels and some heart health risk factors
April 20, 2018 - Improving job prospects unlikely to control opioid epidemic
April 20, 2018 - Skin Sensor Might Someday Track Alcoholics’ Booze Intake
April 20, 2018 - The relevance of GABA for diabetes highlighted in two new studies
April 20, 2018 - Novel method enables fast and noninvasive assessment of tumor status
April 20, 2018 - IU psychologist receives NIH grant to study earliest phases of language learning in children
April 20, 2018 - Walking fast lowers risk of hospitalization in heart patients, shows study
April 20, 2018 - Study reveals surprising insights into RNA-binding proteins
April 20, 2018 - Young victims of cyberbullying twice as likely to attempt suicide and enact suicidal behavior
April 20, 2018 - Role of UBE3A enzyme in Angelman syndrome
April 20, 2018 - NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees
April 20, 2018 - High-tech microscope reveals how cancer-causing virus anchors itself to human DNA
April 20, 2018 - Experimental compound reduces destructive inflammation to improve stroke outcome
April 20, 2018 - The May issue of Drug Discovery Today is a Special Issue and will be published very soon
April 20, 2018 - Larger families linked to heightened tooth loss risk for moms
April 20, 2018 - Scientists develop tiny fluorescent probe that seeks out GLUT5 and detects cancer cells
April 20, 2018 - The Swedish Childhood Cancer Foundation awards grant to KI researchers
April 20, 2018 - AMSBIO’s MC-Easy minicircle technology allows sustained transgene expression in quiescent cells and tissues
April 20, 2018 - Researchers use optogenetics to treat chronic pain
April 20, 2018 - Discovery of 100 new genes may aid research into pigmentation
April 20, 2018 - AYOXXA introduces new LUNARIS Mouse 12-Plex Th17 Kit for quantitative analysis of Th17 cell biology
April 20, 2018 - Compound derived from immune cells treats psoriasis in mice
April 20, 2018 - GABA-transaminase deficiency – Genetics Home Reference
April 20, 2018 - Key heart risks decline for older Americans
April 20, 2018 - UD professor wins $2.3 million grant from NIH for research on Achilles tendinopathy
April 20, 2018 - Researchers discover unique protein in malaria parasite that could be new drug target
April 20, 2018 - Bio-Techne expands automation capabilities of popular RNAscope ISH technology
Potential drug targets for ALS revealed in study using CRISPR

Potential drug targets for ALS revealed in study using CRISPR

image_pdfDownload PDFimage_print
An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/Wikipedia

In a new application of gene-editing technology, researchers at the Stanford University School of Medicine have gleaned insights into the genetic underpinnings of amyotrophic lateral sclerosis, a neurodegenerative disease that’s notoriously tricky to parse.

The team’s findings are a step toward demystifying how the disease progresses and could even help lay the groundwork for new therapeutic targets.

ALS, also known as Lou Gehrig’s disease, erodes muscle function and impairs the brain’s ability to communicate with the body, making simple voluntary muscle movements—such as brushing your teeth, talking or even breathing—exceedingly difficult and, eventually, impossible. ALS falls into a category of neurodegenerative diseases that all share a common “signature”—abnormal protein clumps that build up in the brain.

In ALS, these protein clumps, or aggregates, are thought to be fatally toxic to neurons, ultimately leading to the devastating physical symptoms of the disease. But the process of the cells’ demise is still largely a black box.

“These toxic protein aggregates are what’s likely driving the pathology in the disease, but no one really knows how they cause neuronal cell death. That’s really what we wanted to probe in this study,” said Aaron Gitler, PhD, professor of genetics. He shares senior authorship with Michael Bassik, PhD, assistant professor of genetics.

Gitler’s and Bassik’s labs used CRISPR-Cas9 gene-editing technology to sort through the entire human genome and pick out the genes that helped neurons shore up defenses against the toxic protein. Not only did some genes give the researchers a deeper mechanistic understanding of the disease itself; a handful seem to hold potential as drug targets, too.

A paper describing the research will be published online March 5 in Nature Genetics. Graduate students Nicholas Kramer and Michael Haney share lead authorship.

A simple but deadly protein

The discovery that mutations in the C9orf72 gene is a relatively common cause of ALS has helped ignite efforts to understand how ALS works at the molecular level. In ALS, the mutated C9orf72 gene contains a huge segment of DNA that repeats itself and, when that part of the gene is erroneously turned into various rogue proteins, they gum up neuronal function and lead to cell death.

“In a healthy person, you might see 10 to 20 of these DNA repeats,” Haney said. “But in ALS, they expand to hundreds or even thousands of repeated segments, and that’s the template for the production of these toxic proteins.”

Gitler and Bassik set out to answer two basic questions: How do the toxic proteins snuff out otherwise healthy neurons? And are there other genes that inherently protect against—or conversely, exacerbate—the effects of the toxic proteins in the brain?

Rather than separately interrogate every gene in the human repository, the researchers used a tactic called genomewide screening, which harnesses CRISPR-Cas9 to alter the function of every single human gene simultaneously. In this case, they used the technology to produce “gene knockouts,” targeting genes with a kind of molecular scissors that makes precise cuts, leaving them unable to carry out normal function.

The gene knockouts, Kramer explained, help the researchers spot genes that either enhance toxicity or prevent it: If you identify a gene and knock it out, and the ALS protein repeats are no longer toxic, then you know that the absence of that gene actually protects the neuron against degeneration. And perhaps more importantly, it may be a potential drug target.

Tmx2: A sentinel of cell death

After systematically knocking out every gene in the human genome and measuring the toxicity of the ALS proteins in cells, the researchers found that about 200 genes, when knocked out, either helped to protect the cell from the toxic proteins or made it more vulnerable to them. To zero in on a smaller set of genes, Haney and Kramer followed up with two subsequent knockout screens in primary mouse neurons.

They found a handful of knockouts that were particularly potent protectors. One, for example, helped block off critical entrances through which the toxic ALS proteins infiltrate the cell and corrupt it. But there was another knockout in particular that caught the group’s attention for its mysterious ability to ward off neural death. The gene normally codes for a protein called Tmx2, which is found in a part of the cell called the endoplasmic reticulum. But when depleted in mouse neurons in a dish, the cells survived nearly 100 percent of the time—quite a jump, considering that the survival rate for normal neurons was 10 percent.

“We could imagine that Tmx2 might make good drug target candidate,” Haney said. “If you have a small molecule that could somehow impede the function of Tmx2, there might be a therapeutic window there.”

Right now, Tmx2’s role in the endoplasmic reticulum isn’t completely clear. But it’s thought to be involved in the response to various environmental stressors, particularly those that trigger cell death. According to the study’s findings, it may be a modulator of other genes that set off the cell-death process.

“We’re still in early phases, but I think figuring out exactly what Tmx2 normally does in a cell is a good place to start—that would hint at what functions are disturbed when these toxic species kill the cell, and it could point to what pathways we should look into,” Kramer said.

More broadly, CRISPR screens like the one in this study have been used to investigate a range of disease pathways. But the team said this is the first time, to their knowledge, that a genomewide human CRISPR knockout screen has been used to discover clues about a neurodegenerative disorder. Gitler and Bassik are currently teaming up to use this same approach to understand additional causes of ALS and even other neurological diseases—Huntington’s, Parkinson’s and Alzheimer’s—that involve toxic proteins. “I think it’s a really exciting application for CRISPR screens, and this is just the beginning,” Bassik said.


Explore further:
Scientists move closer to treatment for Huntington’s disease

More information:
CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9orf72 dipeptide-repeat-protein toxicity, Nature Genetics (2018). nature.com/articles/doi:10.1038/s41588-018-0070-7

Journal reference:
Nature Genetics

Provided by:
Stanford University Medical Center

Tagged with:

About author

Related Articles